Activation of the cytokine network in familial Mediterranean fever

Journal of Rheumatology

Volumn 26, Issue 4, 1999, Pages 890-897

  Gang, Nelli ^b   Drenth, Joost P H ^b   Langevitz, Pnina ^b   Zemer, Deborah ^b   Brezniak, Naphtali ^b   Pras, Mordechai ^b   Van Der Meer, Jos W M ^a   Livneh, Avi ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Acute Phase Proteins; Cytokines; Familial Mediterranean Fever

Indexed keywords

ACUTE PHASE PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; C REACTIVE PROTEIN; COLCHICINE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; PREDNISONE; SERUM AMYLOID A; STEROID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ACUTE PHASE RESPONSE; ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; BLOOD SAMPLING; CLINICAL ARTICLE; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENETIC DISORDER; HUMAN; INFLAMMATION; INTRAARTICULAR DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; APOLIPOPROTEINS; C-REACTIVE PROTEIN; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHOSPHOLIPASES A; RADIOIMMUNOASSAY; RECEPTORS, TUMOR NECROSIS FACTOR; SERUM AMYLOID A PROTEIN;

EID: 0032964187     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967;43:227-53.
2. Touitou I, Ben-Chetrit E, Notarnicola C, et al. Familial Mediterranean fever clinical and genetic features in Druzes and in Iraqi Jews: a preliminary study. J Rheumatol 1998;25:916-9.
3. Livneh A, Langevitz P, Zemer D, et al. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996;26:612-27.
4. Zemer D, Revach M, Pras M, et al. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 1974;291:932-4.
5. Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986;314:1001-5.
6. The International FMF Consortium. Ancient missense mutations in a new member of Roret gene family are likely to cause familial Mediterranean fever. Cell 1997;90:797-807.
7. The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nature Genet 1997;17:25-31.
8. Matzner Y, Brzezinski A. C5a-inhibitor deficiency in peritoneal fluids from patients with familial Mediterranean fever. N Engl J Med 1984;311:287-90.
9. Matzner Y, Partridge REH, Levy M, Babior B. Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever. Blood 1984;63:629-33.
10. Ayesh SK, Azar Y, Babior BM, Matzner Y. Inactivation of interleukin-8 by the C5a-inactivating protease from serosal fluid. Blood 1995;81:1424-7.
11. Dinarello CA. Cytokines: interleukin-1 and tumor necrosis factor (cachectin). In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: basic principles and clinical correlates. New York: Raven Press; 1988:195-208.
12. Golde DW, Gasson JC. Cytokines: myeloid growth factor. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: basic principles and clinical correlates. New York: Raven Press; 1988:253-61.
13. Schattner A, Lachmi M, Livneh A, Pras M, Hahn T. Tumor necrosis factor in familial Mediterranean fever. Am J Med 1991;90:434-8.
14. Özyilkan E, Simsek H, Telatar H. Tumor necrosis factor in familial Mediterranean fever. Am J Med 1992;92:416-8.
15. Rozenbaum M, Katz R, Rozner I, Pollack S. Decreased interleukin 1 activity released from circulating monocytes of patients with familial Mediterranean fever during in vitro stimulation by lipopolysaccharide. J Rheumatol 1992;19:416-8.
16. Erken E, Gunesacar R, Ozbek S, Konca K. Serum soluble interleukin-2 receptor levels in familial Mediterranean fever. Ann Rheum Dis 1996;55:852-5.
17. Van Deuren M, van der Ven-Jongekrijg J, Keuter M, Demacker PNM, van der Meer JWM. Cytokine production in whole blood cultures. J Int Fed Clin Chem 1993;5:216-21.
18. Van der Meer JWM, Endres S, Lonnemann G, et al. Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro. J Leukoc Biol 1988;43:216-23.
19. Drenth JPH, van Uum SHM, van Deuren M, Pesman GJ, van der Ven-Jongekrijg J, van der Meer JWM. Endurance run increases circulating IL-6 and IL-1 ra but downregulates ex vivo TNF-α and IL-16ß production. J Appl Physiol 1995;79:1497-503.
20. Poutsiaka DD, Clark BD, Vannier E, Dinarello CA. Production of interleukin-1 receptor antagonist and interleukin-1ß by peripheral blood mononuclear cell is differentially regulated. Blood 1991;78:1275-81.
21. Morrison M. The determination of the exposed proteins of membranes by the use of lactoperoxidase. Methods Enzymol 1974;32:103-9.
22. Langone JJ. Radioiodination by use of the Bolton-Hunter and related reagents. Methods Enzymol 1980;70:221-5.
23. Helle M, Boeije L, De Groot E, De Vos A, Aarden L. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera. J Immunol Methods 1991;138:47-56.
24. Barrera P, Boerbooms AMT, Janssen EM, et al. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor α, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy. Arthritis Rheum 1993;36:1070-9.
25. Hazenberg BPC, Limburg PC, Bijzet J, van Rijswijk MH. Monoclonal antibody-based ELISA for human SAA. In: Natvig JB, Førre Ø, Husby G, et al, editors. Amyloid and amyloidosis. Dordrecht: Kluwer Academics; 1990;898-901.
26. 2 in arthritis plasma using a newly developed sandwich ELISA. Br J Rheumatol 1992;31:175-8.
27. Kishimoto T. The biology of interleukin-6. Blood 1989;74:1-10.
28. 2. Function and pharmacological regulation. Biochem Pharmacol 1987;36:2429-36.
29. Ballou SP, Lozanski G. Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein. Cytokine 1992;4:361-8.
30. Schattner A, Gurevitz A, Zemer D, Hahn T. Induced TNF production in vitro as a test for familial Mediterranean fever. Q J Med 1996;89:205-10.
31. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1 and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990;75:40-7.
32. Aderka D, Le JM, Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells and in mice. J Immunol 1989;143:3517-23.
33. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor P55. Blood 1994;83:113-8.
34. Rivas AL, Tintle L, Kimball ES, Scarlett J, Quimg FW. A canine febrile disorder associated with elevated interleukin-6. Clin Immunol Immunopathol 1992;64:36-45.
35. Drenth JPH, Haagsma CJ, van der Meer JWM, and International Hyper-IgD Study Group. Hyperimmunoglobulinemia D and periodic fever. The clinical spectrum in a series of 50 patients. Medicine (Baltimore) 1994;73:133-44.
36. Drenth JPH, van Deuren M, van der Ven-Jongekrijg J, Schalkwijk CG, van der Meer JWM. Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood 1995;85:3586-93.
37. Drenth JPH, Mariman ECM, van der Velde-Visser SD, Ropers HH, van der Meer JWM, International Hyper-IgD Study Group. Location of the gene causing hyperimmunoglobulinemia D and periodic fever syndrome differs from that for familial Mediterranean fever. Hum Genet 1994;94:616-20.
38. Livneh A, Drenth JPH, Klasen IS, et al. Familial Mediterranean fever and hyperimmunoglobulinemia D syndrome: 2 diseases with distinct clinical, serological and genetic features. J Rheumatol 1997;24:1558-63.
39. Allen JN, Herzyk DJ, Wewers MD. Colchicine has opposite effects on interleukin-1ß and tumor necrosis factor-α production. Am J Physiol 1991;261:L315-21.
40. Entzian P, Schlaak M, Seitzer U, Bufe A, Acil Y, Zabel P. Antiinflammatory and antifibrotic properties of colchicine: implications for idiopathic pulmonary fibrosis. Lung 1997;175:41-1.
41. Endres S, Whitacker RED, Ghorbani R, Meydani SN, Dinarello CA. Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1ßand tumor necrosis factor-α ex vivo. Immunology 1996;87:264-70.